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Abstract
Alveolar type (AT)I and ATII cells are central to maintaining
normal alveolar fluid homeostasis. When disrupted, they
contribute to the pathogenesis of acute lung injury (ALI) and acute
respiratory distress syndrome. Research on ATII cells has been
limited by the inability to propagate primary cells in vitro to study
their specific functional properties. Moreover, primary ATII cells
in vitro quickly transdifferentiate into nonproliferative “ATI-like”
cells under traditional culture conditions. Recent studies have
demonstrated that normal and tumor cells grown in culture with
a combination of fibroblast (feeder cells) and a pharmacological
Rho kinase inhibitor (Y-27632) exhibit indefinite cell proliferation
that resembled a “conditionally reprogrammed cell” phenotype.
Using this coculture system, we found that primary human ATII
cells (1) proliferated at an exponential rate, (2) established
epithelial colonies expressing ATII-specific and “ATI-like”mRNA
and proteins after serial passage, (3) up-regulated genes important
in cell proliferation and migration, and (4) on removal of feeder
cells and Rho kinase inhibitor under air–liquid interface
conditions, exhibited bioelectric and volume transport
characteristics similar to freshly cultured ATII cells. Collectively,
our results demonstrate that this novel coculture technique breaks
the in vitro ATII cell proliferation barrier while retaining cell-
specific functional properties. This work will allow for a significant
increase in studies designed to elucidate ATII cell function with the
goal of accelerating the development of novel therapies for alveolar
diseases.
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Clinical Relevance
We describe a novel coculture technique that breaks the in vitro
alveolar type II cell proliferation barrier while retaining cell-
specific functional properties. This technique increases the
supply of human primary alveolar type II cells and allows for
additional studies to be performed focused on important
biological and functional processes relevant to the physiology
and pathophysiology of alveolar lung diseases.
It is critical that the alveolar epithelium
maintains a thin liquid layer lining to
promote proper surface tension, gas
exchange, and protection from inhaled
toxins and pathogens. Alveolar type
(AT)I and ATII epithelial cells are damaged
during inflammation associated with
acute lung injury (ALI) and acute
respiratory distress syndrome (1–4).
Resolution of ALI through removal of
alveolar edema fluid has been the focus of
many in vitro and in vivo studies (5–7).
However, one consistent limitation of
these studies has been that ATII cells
in vitro quickly transdifferentiate (i.e., lose
their ATII cell–specific markers and gain
“ATI-like”–specific markers) and do not
proliferate under traditional culture
conditions (8–10). The failure of human
primary ATII cells to proliferate greatly
limits the number of studies designed to
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elucidate the pathogenesis of human
alveolar diseases.
Previous attempts have been made to
promote ATII cell proliferation in vitro.
In vivo, fibroblasts reside beneath alveolar
lung epithelia and make contact with ATI
and ATII cells through gaps within the
basement membrane (11). Fibroblasts
secrete important soluble factors (e.g.,
keratinocyte growth factor [KGF])
that have been reported to limit
transdifferentiation and to promote ATII
cell proliferation (11–15). ATII cells
cocultured with human or rat fibroblasts or
exposed to KGF exhibit surfactant mRNA
expression in vitro for extended periods,
suggesting that KGF (added or presumably
secreted by fibroblasts) was in part
responsible for retaining ATII cell
differentiation in vitro (12). These studies
also reported that KGF could stimulate
ATII cell proliferation (14, 16, 17), which
could be antagonized by the transforming
growth factor (TGF)-b (18). However,
a precise genetic characterization of the
proliferating cells was not reported, nor
were KGF-treated ATII cells amendable to
serial passage and expansion.
Recent published work has
demonstrated the ability of human cells
(e.g., keratinocytes and airway epithelial
cells) to proliferate indefinitely, without the
transduction of exogenous viral or cellular
genes, by addition of a pharmacological
inhibitor of the Rho kinase signaling
pathway (Y-27632, “Y”) (19–22) in the
presence of mouse feeder cells (23). These
“conditionally reprogrammed cells” were
shown to exhibit a stem cell–like phenotype
with an up-regulation of adult stem cell
genes (e.g., a6/b1 integrin, DNp63a) (24).
Passaged CRCs could revert to their
original epithelial cell phenotype on
removal of the feeder cells and “Y.” This
recently developed cell culture technology
has the potential to accelerate alveolar
epithelial research by expanding the
availability of human alveolar cells and,
thus, increasing cell-specific studies
designed to target therapeutics against ALI
and acute respiratory distress syndrome.
We tested the hypothesis that primary
human ATII cells cocultured with feeder
cells and “Y” would exhibit a break in the
in vitro ATII cell proliferation barrier and
undergo serial passage and expansion. Due
to the ATI transdifferentiation that affects
most ATII cells in vitro, we genetically
characterized the expanded cells on tissue
culture plastic and after culture on an
air–liquid interface by mRNA sequencing
analyses. Finally, using electrophysiological
and imaging techniques, we explored
whether human ATII cells that have
undergone serial passage and removal of
feeder cells and whether “Y” would be useful
for studies of ion transport processes that
mediate normal and alveolar fluid balance
and responses to pulmonary edema.
Materials and Methods
Additional experimental details are available
in the online supplement.
Human ATII Isolation
Primary ATII cells were isolated from
human lungs as previously described with
slight modifications (29).
Cell Culture
The coculturing technique used in this study
was as previously described (23) with slight
modifications.
ATII Proliferation Assay
Freshly isolated or passaged ATII cells were
grown with feeder cells and “Y” on rat tail
collagen-1–coated 12- or 24-well plates in
“base media” as described above. After
72 hours, cells were incubated with the
Click-iT EdU labeling reagent, and the cells




Total RNA was extracted from freshly
isolated, freshly cultured, or passaged ATII
cells under cocultured conditions as
previously described (29).
Immunofluorescence
Freshly isolated or passaged ATII
suspensions (cytospins) were used for
immunocytochemistry analysis as described
previously (29). Cells were probed with
antibodies against the HTII-280 protein (a
gift from Dr. Leland Dobbs, San Francisco,
CA), AQP-5 (Santa Cruz Biotechnology,
Santa Cruz, CA), SP-A (Santa Cruz), SP-C
(Santa Cruz), or podoplanin (Santa Cruz).
Alveolar Surface Liquid
Height Measurements
Alveolar surface liquid (AvSL) was imaged
and calculated as previously described (29).
Data Expression and
Statistical Analysis
All experiments were performed in
triplicate, and cells were obtained from at
least three different patient specimens. Data
are presented as means 6 SD and were
analyzed by one-way ANOVA. Differences
were considered significant if P , 0.05.
Results
Feeder Cells and Rho Kinase Inhibitor
Induce ATII Cell Proliferation and
Expansion In Vitro
Figure 1A depicts the in vitro coculture cell
model in which isolated primary human
ATII cells from rejected donated lungs were
cultured with irradiated feeder cells (1:3)
and “Y” and expanded on rat tail collagen-
1–coated plastic dishes. To determine the
contribution of each component to the
culture process, ATII cells were plated
with base media alone (Figure 1Bi), with
“Y” (Figure 1Bii), with feeder cells
(Figure 1Biii), or with the combination of
feeder cells and “Y” (Figure 1Biv) and
imaged 4 days after seeding. Human ATII
cells plated with base media alone did not
proliferate and formed large, round, flat,
“ATI-like” cells, as previously reported (25).
In contrast, ATII cells plated with the
combination of feeder cells and “Y”
generated islands of epithelial-like colonies
surrounded by feeder cells. ATII cells plated
with feeder cells or “Y” alone did not
establish the well-formed epithelial colonies
observed when grown under the feeder
and “Y” combination.
Human ATII cells plated with base
media alone (Figure 1Ci) or with the
combination of feeder cells and “Y” were
imaged 8 days after seeding (Figure 1Cii).
The coculture technique, but not base
media alone, gave rise to a marked increase
in the number of epithelial-like cells within
8 to 10 days. Cells were trypsinized at
approximately 90% confluence and replated
(passaged) on rat tail collagen 1–coated
plastic dishes in the presence of feeder
cells and “Y” for serial passage (p1–p3)
(Figure 1Ciii–v), and cell number was
recorded approximately 8 to 10 days after
passaging. Initially, 2.5 3 105 ATII cells
were plated on each p60 plastic dish, and
approximately 4.0 3 106 cells were counted
8 to 10 days later. Approximately the
same number of cells was counted after
each passage (Figure 1D). A plot of
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population doublings for ATII cells grown
with base media alone or with feeder cells
and “Y” revealed that ATII cells grown
with feeder cells and “Y” reached
approximately 31 population doublings by
63 days after original seeding (Figure 1E).
Characterization of Proliferating
Human Primary ATII Cells
The Click-iT EdU cell proliferation assay
was used to identify newly synthesized
cellular DNA. ATII cells were plated onto
12-well dishes with base media alone
(Figure 2Ai) or with feeder cells and “Y”
(Figure 2Aii). Cell proliferation (green) and
nuclei (blue) were imaged with fluorescence
microscopy 72 hours after seeding. ATII
cells grown in base media alone did not
show evidence for cell proliferation,
whereas a significant population of ATII
cell colonies cocultured with feeder cells
and “Y” stained positive for the
proliferation marker.
To analyze the phenotype of the
proliferating cells, the Click-iTEdU assay
was combined with an antibody targeted
against an apical epitope on ATII cells
(HTII-280) (26) and imaged using confocal
microscopy. Fresh ATII cells plated with
base media alone failed to exhibit evidence
of cell proliferation (green) despite the
presence of HTII-280–positive (red) ATII cells
(Figure 2Bi). In contrast, a significant portion
of freshly isolated ATII cells plated with
feeder cells and “Y” dually stained for DNA
synthesis and HTII-280 (Figure 2Bi).
Further attempts were made to
characterize the passaged (p2) ATII cells that
were proliferating under these coculture
conditions. Using a pan-cytokeratin antibody
to identify epithelial cells, the majority of the
proliferating cells stained positive for the
pan-cytokeratin antibody (Figure 2Ci).
Using three different antibodies (HTII-280,
SP-A, or SP-C) to identify the presence of
Figure 1. Expanding primary human alveolar type (AT)II cells using feeder cells and a pharmacological inhibitor of the Rho kinase signaling pathway
(Y-27632, “Y”). (A) Schema illustrates the recently developed coculture. (B) ATII cells (2.53 105) were grown with base media alone (i), with “Y” (10 mM) (ii),
with feeder cells (7.5 3 105) (iii), or with combination of feeder cells and “Y” (iv) and imaged 4 days after seeding. (C) Fresh ATII cells were grown on
rat tail collagen-1–coated plastic dishes with base media alone (i) or with feeder cells and “Y” (ii) and imaged 10 days after seeding. Cells were trypsinized
and further passaged with feeder cells and “Y” (p1–p3; iii–v). (D) Total cell count was recorded for ATII cells plated alone (final ATII) or in combination
with feeder cells 1 “Y” (final F 1 “Y”) up to passage 8 (p8), and a plot of population doublings versus time (days) was constructed (E). All images were
taken using phase contrast microscopy under 203 objective. Values are mean 6 SD (n > 4 different lungs).
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proliferating ATII cells at p2, we noted that
very few of the proliferating cells were
positive for ATII cell markers
(Figure 2Cii–iv), suggesting that the
transdifferentiation process may be retained
in passaged cells. To test this hypothesis,
we colabeled p2 ATII cell feeder plus “Y”
cultures with two different antibodies against
ATI markers (podoplanin and aquaporin-5
[AQP-5]) and imaged cells using
fluorescence microscopy. A significant
number of the proliferating positive cells also
stained positive (red) for podoplanin and
AQP-5 (Figures 2Cv and 2Cvi), providing
evidence that these cultures (p2) had
transdifferentiated and that ATI-like cells
were presumably the cells that were
proliferating. Transdifferentiated ATI-like
cells did not proliferate when grown with
base media alone (Figure 2D).
Recent evidence from Kumar and
colleagues (27) demonstrated that distal
airway stem cells can lead to alveoli lung
structure regeneration. These p63/keratin
5–expressing distal airway stem cells were
shown to assemble into “pods” that
exhibited expression of markers typical of
alveolar epithelial cells. To explore
expression of keratin 5 in proliferating ATII
cells, we measured RNA and protein
expression in freshly isolated, passaged
(p2), and air-liquid interface differentiated
ATII preparations. First, we observed that
freshly isolated primary ATII cells that
stained positive for proliferation (Click-iT
EdU positive [green]) were negative for
keratin 5 (Figure 2Di), suggesting the
absence of contaminating basal cells in
the initial ATII isolation preparations.
We identified an increase in keratin
5–positive cells when ATII cells were
cultured under air-liquid interface
conditions (Figure 2Dii), in passaged
(p2) ATII cells grown with feeder cells
and “Y” (Figure 2Diii), and in passaged
(p2) cells cultured under air-liquid
interface conditions (Figure 2Div). Deep
sequencing analyses of RNA isolated
from all four conditions mimicked the
protein expression pattern of keratin 5
(Figure 2Dv). Hematoxylin and eosin
staining was performed on fixed passaged
(p2) ATII cells cultured on membrane
supports for 5 days under air-liquid
interface conditions (Figure 2Dvi). No
ciliated cells were observed in these
monolayers.
Coculture Conditions Do Not Inhibit
ATII Cell Transdifferentiation
Semiquantitative PCR analyses were
performed on mRNA from freshly isolated
ATII cells and from passaged ATII cells
(p0–p2) grown with feeder cells and “Y”
(Figure 3A). Surfactant protein (SP)-A
mRNA was expressed in freshly isolated
Figure 2. Feeder cells and “Y” promote ATII cell DNA synthesis. ATII cell characterization and DNA synthesis using feeder cells and “Y” coculture
conditions. Newly synthesized DNA was examined using the Click-iT EdUAlexa Fluor 488 cell proliferation kit. (A) Freshly isolated human ATII cells
were plated onto rat tail collagen-1 plates with base media alone (i) or with feeder cells and “Y” (ii) for 72 hours, and proliferating cells (green) and cell
nuclei (blue) were imaged using confocal microscopy under 403 objective. (B) Freshly isolated ATII cells, treated with the Click-iT EdU Assay, were
probed for an ATII membrane protein (HTII-280, red) by antibody detection to identity proliferating cells (green) in base media alone (i) or grown with feeder
cells and “Y” (ii). (C) Passaged (p2) ATII cells expressed proliferating positive cells (green) and were colabeled with a pancytokeratin antibody (i),
antibodies against ATII cell markers (HTII-280 [ii], SP-A [iii], SP-C [iv]), or antibodies against ATI markers (podoplanin [v], AQP-5 [vi]). (D) ATII cells were
probed using an antibody for keratin 5 under the following conditions: freshly isolated with feeder cells and “Y”, (ii) freshly cultured ATII cells under air-liquid
interface conditions, (iii) p2 ATII cells with feeder cells and “Y”, or (iv) p2 ATII cells cultured under air-liquid interface conditions. RNA deep sequencing
analyses (FPKM value) for keratin 5 expression of all four conditions (v). Hematoxylin and eosin staining was performed on p2 ATII air-liquid interface
cultures revealing flat nonciliated single cell monolayers (vi). Values are mean 6 SD (n > 3 different lungs).
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ATII cells and appeared to decrease slightly
with cell passaging. SP-B, -C, and
-D mRNA levels were also expressed
through early cell passage (p1) but
decreased through additional cell passing
(p2). In parallel, we examined the
expression of RNA transcripts identified as
present in ATI and “ATI-like” cells (28).
AQP-5 and podoplanin mRNA expression
were absent in the freshly isolated ATII
preparations, suggesting little or no ATI cell
contamination. However, after ATII cells
were passaged once under the coculture
condition, AQP-5 and podoplanin
expression was observed and increased as
cells underwent serial passage. Expression
of RNA was performed by RT-PCR within
freshly isolated and passaged ATII cells
and confirmed these relationships
(Figure 3B). Moreover, a more quantitative
approach was explored using deep
sequencing analyses. The expression
profiles revealed similar patterns for
freshly isolated ATII cells versus passaged
(p2) cells (Table 1).
Cytospin preparations of freshly
isolated ATII cells and cells grown with
feeder cells and “Y” (p0–p2) were examined
by immunocytochemistry using antibodies
against the ATII cell membrane protein
(HTII-280) and the ATI cell marker
(AQP-5). Freshly isolated cells (Figure 3C,
i) expressed the HTII-280 (red) ATII cell
surface protein, which decreased on serial
passage. In contrast, AQP-5 (green) was not
expressed in freshly isolated ATII cells.
However, expression increased as cells
underwent serial passage (Figure 3Cii–iv).
This pattern was recapitulated in the deep
sequencing analyses (Table 1). Collectively,
these data suggest that the ATII cell
transdifferentiation process persisted in the
presence of feeder cells and “Y.”
Gene Expression Profile by RNA Deep
Sequencing Analyses
To further characterize the effects of feeder
cells and “Y” at the gene expression level
Figure 3. Fresh or passaged human ATII cells mRNA and protein expression. (A) mRNA expression of ATII cell–specific surfactant proteins (SP-A, -B, -C, -D)
and markers for ATI /“ATI-like” cells (AQP-5 and podoplanin) were examined by semiquantitative PCR. (B) Quantitation of gene expression profiles by ImageJ
analysis was performed in freshly isolated or passaged ATII cultures grown with feeder cells and “Y” (normalized against glyceraldehyde 3-phosphate
dehydrogenase [GAPDH]). (C) Immunocytochemistry was performed on cytospin preparations of fresh (i), freshly cultured (ii), or passaged ATII cells grown with
feeder cells and “Y” (p1; iii) or (p2; iv). Cells were probed using an ATII-specific antibody (HTII-280, red), an ATI/“ATI-like” cell-specific antibody (AQP-5, green), and
nuclei stain (Hoechst, blue) to characterize cells at each stage by confocal microscopy using a 403 objective. Values are mean 6 SD (n > 3 different lungs).
Table 1: Differentially Expressed Genes by RNA Deep Sequencing Analyses










SFTP-A1* Surfactant, pulmonary-associated protein, A1 7,879 6 2,887† 4,275 6 2,078 259 6 244 22 6 9
SFTP-A2* Surfactant, pulmonary-associated protein, A2 9,872 6 4,049 3,664 6 2,830 63 6 29 126 6 59
SFTP-B* Surfactant, pulmonary-associated protein, B 33,827 6 28659 5,025 6 1,853 158 6 142 42 6 28
SFTP-C* Surfactant, pulmonary-associated protein, C 14,082 6 10,060 110 6 57 68 6 47 7.1 6 6.6
SFTP-D Surfactant, pulmonary-associated protein, D 811 6 238 109 6 28 17 6 14 2.8 6 1.9
AQP-5 Aquaporin-5 26 6 8.6 30 6 11 286 6 78 107 6 19
PDPN Podoplanin 8.2 6 4.3 30 6 12 37 6 10 35 6 15
CFTR Cystic fibrosis transmembrane conductance regulator 8.6 6 3.9 7.5 6 2.0 7.5 6 5.7 3.4 6 0.3
SCNN1a Sodium channel, non–voltage-gated 1a subunit 114 6 21 279 6 63 84 6 3.8 111 6 20
SCNN1b Sodium channel, non–voltage-gated 1b subunit 21 6 5.6 78 6 16 6.1 6 0.6 12 6 1.4
SCNN1g Sodium channel, non–voltage-gated 1g subunit 4.1 6 1.2 11 6 3.7 0.4 6 0.1 1.6 6 0.1
Definition of abbreviations: ATII, alveolar type II; p2, passage 2.
*Due to fragment per kilobase of exon per million fragments mapped (FPKM) values above limit of detection, reads per kilobase of transcript per million
mapped (RPKM) values are presented.
†Values are average FPKM or RPKM.
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of human ATII cells, RNA deep sequencing
analyses were performed to identify and
compare gene expression profiles from the
lungs of three separate individuals in (1)
freshly isolated ATII cells, (2) freshly isolated
ATII cells grown on porous supports for
5 days under air-liquid interface conditions
(no feeder cells and no “Y”), (3) passaged
(p2) ATII cells grown on plastic with feeder
cells and “Y,” and (4) passaged (p2) ATII
cultures grown under air-liquid interface
conditions for 5 days with no feeder cells
and no “Y” (Figure 4B).
The number of genes expressed in ATII
cells was filtered by analyzing only signals
with a fragment per kilobase of exon per
million fragments mapped (FPKM) > 10.
Using these parameters, over 9,000 total
genes were identified. As a test of our freshly
isolated ATII cells, the 25 most abundant
genes expressed in our ATII cells (see Table
E2 in the online supplement) were tabulated
and compared with a previous report (28),
with reasonable concordance (z 60%).
Hierarchical clustering heat maps of all
expressed genes revealed a clear pattern
(Figure 4A). Overall, fresh ATII cells (cultured
on plastic or grown under air-liquid interface
conditions) clustered together relative to
feeder cell and “Y” passaged (p2) cells grown
on plastic or air-liquid interface, indicating
a large overall effect of feeder cells and “Y” on
global gene expression. For fresh ATII cells,
air-liquid interface cultures clustered together
and were distinguishable from freshly isolated
cells. However, for p2 cultures, the gene
expression clustered by individual donor
specimen, not plastic versus air-liquid
interface culture condition, suggesting that the
feeder cells and “Y” culture system dominated
over culture condition.
To gain insight into which cell phenotype
(i.e., fresh ATII versus “ATI-like” after
transdifferentiation) proliferated in feeder
cells and “Y” media, Pearson product-
moment correlation coefficients for gene
expression were measured among the four
different cell culture conditions (Figure 4B).
We observed that (1) fresh ATII cells cultured
under air-liquid interface conditions were
correlated with freshly isolated ATII cells at
an 0.82 level, the difference reflecting “ATI-
like” cell transdifferentiation; (2) passaged
(p2) cells grown on plastic were more like
freshly isolated ATII cells under air-liquid
interface conditions (0.77) than freshly
isolated ATII cells (0.65); and (3) passaged
(p2) cells under air-liquid interface conditions
were more like fresh ATII cells under air-
liquid interface conditions (0.82) than freshly
isolated ATII cells (0.71). The principal
component analysis for all conditions (see
Figure E1) demonstrated similar
relationships. These data suggest that the p2
cells on plastic with feeder cells and “Y” and
the p2 cells under air-liquid interface
conditions were more like “AT-I like”
transdifferentiated cells rather than freshly
isolated ATII cells.
Enrichment pathway analyses for
passaged (p2) ATII cells grown on plastic with
feeder cells and “Y” versus freshly isolated
ATII cells revealed up-regulation of cellular
pathways involved in epithelial development,
adhesion pathways, signaling, and epithelial
cell differentiation in p2 cells (Table E2). A
few of the top differentially expressed genes
within these pathways included CD24,
CDK6, CDK8, CDK18, EPH-A1, EPH-B2,
MMP-2, MMP-14, and ADAM-9. These
molecules are associated with stemness,
growth control, cell cycle progression, cell
migration, cell–cell interaction, and
remodeling, all indicative of the highly
proliferative and migratory behavior of the
passaged ATII cells. In addition, we identified
the top down-regulated biological processes
between passaged (p2) ATII cells versus
freshly isolated ATII cells. The lipid
metabolism pathway (a highly relative
process for ATII cells) was significantly
down-regulated (P value, 5.49E205) in p2
ATII cells grown on plastic with feeders
plus “Y” compared with freshly isolated ATII
cells. In addition, gene expression analyses
(FPKM average values) for markers of ATI
cells, as well as cystic fibrosis transmembrane
conductance regulator (CFTR) and subunits
of ENaC (a, b, g), were performed (Table
E1) for all four groups and overall agreed
with the RT-PCR data (Figure 3).
Concurrently, we investigated epithelial
stem cell marker expression in fresh ATII cells
versus passaged ATII cells grown with feeder
cells and “Y.” Recent work demonstrated
a rapid induction of epithelial stem cell
markers when primary cells were cultured
under these novel coculture conditions. The
a6 and b1 integrins, reported to play
a significant role in colony forming efficiency
and fast attachment to the basal membrane
matrix (24), were expressed 13-fold and 4.4-
fold higher in ATII cells cultured with feeder
cells and “Y,” respectively, than in freshly
isolated ATII cells. The DNp63a transcription
factor (required for the maintenance of basal
stem cells) was up-regulated 48-fold (Table 2).
Figure 4. RNA deep sequencing analyses of human ATII cells. (A) A heat map of differentially
expressed genes is displayed between fresh ATII cells versus passaged (p2) ATII cells (with feeder
cells and “Y”) and fresh versus p2 air-liquid interface cultures 5 days after seeding. (B) Pearson
correlation coefficients for all genes between all four conditions were calculated.
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Passaged ATII Cells Retain Ion
Transport Function
Fresh isolated (red, “p0”) or passaged ATII
cells cultured with feeder cells and “Y”
(black, “p2”) were plated onto rat tail
collagen-1–coated supports and grown
under air-liquid interface conditions
without feeder cells and without “Y.” Basal
transepithelial resistances (TER, z 450
V$cm2) and short-circuit currents (Isc, z15
mA/cm2) were measured 5 days after
seeding and were found to be similar
between fresh and passaged ATII–air-liquid
interface cultures (Figure 5A).
Different sequences of administration of
Na1 and Cl2 transport inhibitors were used
to investigate the components of Isc. The
ENaC inhibitor amiloride (1024 M) was used
to measure the basal contribution of ENaC-
mediated Na1 absorption (Figure 5B), and
the inhibitor CFTRinh172 (10 mM) was used
to estimate basal CFTR-mediated Cl2
secretion (Figure 5D). Like freshly cultured
ATII cells, passaged (p2) ATII cells under
air-liquid interface conditions exhibited
significant amiloride-sensitive currents
(Figure 5C). Basal CFTR Cl2 secretion
constituted a smaller component of basal Isc
in fresh and passaged ATII cultures
(Figure 5E).
Uridine-59-triphosphate (UTP), a major
endogenous regulator of ATII ion transport
(29), was added to amiloride-pretreated freshly
cultured and passaged ATII cells (Figure 5B).
UTP (10 mM) stimulated a transient Cl2
secretion in both cell types (Figure 5C). When
cells were pretreated with the CFTR inhibitor,
UTP-stimulated Cl2 secretion was inhibited,
suggesting that CFTR mediated UTP-
stimulated Cl2 secretion in both culture
conditions (Figure 5E). To identify
the potential role of Ca12–activated
chloride channels in Cl2 secretion,
a nonselective Cl2 transport inhibitor
(trifluoromethylphenol, 50 mM), was added
to fresh and passaged ATII–air-liquid
interface cultures (Figures 5B and 5D) after
CFTR inhibition. A modest inhibition in Isc
was detected in fresh and passaged ATII
cultures (Figures 5C and 5E).
To investigate whether ENaC-mediated
Na1 transport could be regulated in
passaged ATII cells as previously reported in
fresh ATII cultures (29), passaged cells were
treated with dexamethasone (1 mM) for 24
hours before Ussing chamber analysis
(Figure E2). Like fresh ATII cells, basal Isc
was significantly higher in passaged ATII
cells treated with dexamethasone compared
with nontreated passaged ATII cells.
To evaluate the gene expression profiles of
selected Na1 (a, b, and g subunits of ENaC)
and Cl2 channels (CFTR), mRNA was
isolated from fresh and passaged ATII cells
and semiquantitative RT-PCR analysis was
performed (Figure 5F). Except for a modest
reduction in b- and g-ENaC at p2, the levels
of ENaC and CFTR RNAs expressed in ATII
cells cultured with feeder cells and “Y” was
similar to freshly isolated ATII cells.
AvSL Regulation in Passaged
ATII Cells
Passaged (p2) ATII cells or freshly isolatedATII
cells were seeded on supports with no feeder
cells and no “Y,” subjected to air-liquid
interface conditions, and challenged with an
apical bolus (30 ml) addition of a 70-kD Texas-
red dextran/PBS solution. Images obtained by
xz scan confocal microscopy after 24 hours
revealed two key observations. First, the rate of
liquid absorption was similar for both cell
types. Second, both cell types achieved a similar
24-hour steady-state AvSL height (29),
suggesting that the homeostatic mechanisms
that regulate AvSL balance in fresh ATII air-
liquid interface cultures were preserved in
passaged ATII cultures (Figures 6A and 6B).
To evaluate extracellular nucleotide
contributions to AvSL homeostasis, passaged
(p2) cells were grown under air-liquid
interface conditions without feeder cells and
without “Y” and treated with UTP (100 mM,
luminal), and changes in AvSL height were
imaged (Figures 6C and 6D). Passaged (p2)
ATII cells exhibited an increase in AvSL
height 10 minutes after UTP addition,
a secretory response similar to previous
reports of freshly cultured ATII cells (29).
Discussion
Over the past 25 years, there has been the
consistent observation that primary adult
human ATII cells do not proliferate
in vitro and within a few days in culture
transdifferentiate into “ATI-like” cells
(8, 10, 30). Little progress has been made
on “breaking” the ATII cell proliferation
barrier, and the transdifferentiation process
can only be partially slowed by growing
primary ATII cells under air-liquid
interface conditions. Although the
transdifferentiation process clearly reduces
the capacity for studies of surfactant
metabolism (i.e., SP-C, SP-D), it may not
affect the ion transport characteristics to
the same degree; gene expression profiles of
ion transport related genes of freshly
isolated versus Day 5 air-liquid interface
ATII cells were quite similar (Figure 5F).
To break the ATII/“ATI-like” cell
proliferation block, primary human ATII
cells (z 2.5 3 105) were plated with
a combination of irradiated feeder cells and
“Y”, as outlined by Liu and colleagues (23).
ATII cells formed proliferating epithelial
colonies throughout the dish surrounded
by the feeder cells, yielding approximately
4 3 106 cells per passage from 2.5 3 105
originally plated cells (Figure 1D). ATII cells
plated under the coculture conditions
underwent approximately 31 population
doublings within 63 days, whereas ATII cells
Table 2: Differentially Expressed Genes Identified as Markers for “Conditionally Reprogrammed Cells”
Gene ID Gene Description Fresh ATII Cells Passaged (p2) ATII Cells Passaged (p2) Air-Liquid Interface Cultures
ITGB1 Integrin, b1 73.7 6 18.3* 313.3 6 52.6 258.6 6 89.4
ITGA6 Integrin, a6 8.3 6 2.6 354.0 6 40.6 82.7 6 37.5
DNp63a Tumor protein p63 1.2 6 0.4 105.3 6 17.9 34.0 6 8.9
CD44 CD44 (Indian blood group) 153.3 6 8.1 118.7 6 7.1 108.4 6 31.6
Notch1 NOTCH1 11.4 6 0.4 18.2 6 1.9 9.7 6 1.2
DLL-1 Delta-like 1 receptor 1.5 6 0.3 11.0 6 2.9 4.5 6 1.3
Definition of abbreviations: ATII, alveolar type II; p2, passage 2.
*Values are fragment per kilobase of exon per million fragments mapped average values 6 SE from three different lungs.
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plated in base media lacked the capacity to
proliferate (Figure 1E).
ATII cells plated with feeder cells and “Y”
were positive for the Click-IT
EdU proliferation probe (Figure 2A, ii, green).
ATII cells grown under coculture conditions
retained surfactant in RNA expression
through p2. Immunofluorescence studies
confirmed that a number of the proliferating
cells in freshly plated cultures stained
positive for an ATII cell membrane protein,
HTII-280 (Figure 2Bii). However, ATII cells
undergoing serial passage (p2) exhibited
a relative decrease in HTII-280 (ii)–, SP-A
(iii)–, and SP-C (iv)–positive proliferating cells
(Figure 2Bi and ii). Although our data
strongly support the notion that the
proliferation barrier for ATII cells in vitro was
“broken” under these coculturing conditions,
the proliferating cells with serial passage
showed decreased ATII markers, suggesting
that transdifferentiated “ATI-like” cells
dominated later passages. Indeed, we observed
that a significant population of proliferating
passaged (p2) ATII cells stained positive for
ATI markers (podoplanin and AQP-5),
suggesting that the “ATI-like” cell phenotype
dominated the proliferation process
(Figure 2Cv and vi). Cells plated directly onto
plastic dishes that promoted the “ATI-like”
cell transdifferentiation did not proliferate,
suggesting these coculture conditions can
induce proliferation of “ATI-like” cells.
We also noted the appearance of keratin 5
expression in our cultures. Keratin 5 expression
first appeared in freshly isolated ATII cultures
under air-liquid interface conditions and
became more prominent in passaged (p2)
cells grown on plastic and under air-liquid
Figure 5. Passaged ATII cultures maintain ion transport properties. (A) Passaged (p2) ATII cells in the absence of feeder cells and “Y” exhibited
transepithelial resistances (TER, V$cm2) and basal short circuit currents (Isc, mA/cm
2) similar to fresh (p0) ATII cells. (B) Isc of fresh (p0) ATII cultures and
passaged (p2) ATII cells were recorded after exposure to the ENaC inhibitor (amiloride, 1024 M), followed by exposure to uridine-59-triphosphate (UTP)
(100 mM), the cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor (172, 10 mM, luminal), and a nonspecific Cl2 channel inhibitor
(trifluoromethylphenol [TFMP], 50 mM) in Ussing chambers. (C) The changes in Isc (DIsc) are summarized. (D) ATII cultures (p0 and p2) were treated with the
CFTR inhibitor followed by UTP (100 mM), amiloride (1024 M), and TFMP (50 mM). (E) DIsc are summarized. (F) Semiquantitative PCR analysis was
performed to identify expression of a-, b-, and g-ENaC and CFTR in fresh and passaged (p0–p2) ATII cells cocultured with feeder cells and “Y.” Values are
mean 6 SD (n > 3 different lungs).
Figure 6. Freshly cultured or passaged ATII cell alveolar surface liquid (AvSL). (A) Freshly cultured (p0)
and passaged (p2) ATII cells grown on porous supports were exposed to a bolus of a 70-kD dextran
fluorophore (Texas red)/PBS solution (30 ml) at 378C, and AvSL height was measured and imaged
(original magnification: 363) by xz scan confocal microscopy. (B) The changes in AvSL height were
plotted over 24 hours after the bolus was added. (C) Passaged (p2) ATII cells were labeled with a 70-
kD dextran fluorophore (Texas red)/PBS solution for 30 minutes at 378C. The solution was aspirated,
and AvSL was imaged (original magnification: 363) in the absence or presence of UTP (100 mM,
luminal) at 0 and 10 minutes by xz scan confocal microscopy. (D) Changes in AvSL height were
quantitated and plotted. Values are mean 6 SD (n > 3 different lungs) *P < 0.05.
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interface conditions. We do not know whether
keratin 5 expression reflects “ATI-like”
differentiation or is an alveolar stem cell
marker. Histological studies confirmed that
keratin 5 expression did not reflect
contaminating airway basal cells with
a capacity for differentiation into ciliated cells
(Figure 2Dvi).
RT-PCR analysis demonstrated that fresh
ATII cells started losing ATII-specific genes
(SP-A, -B, -C, -D) and started to express ATI
makers (AQP-5, podoplanin) as early as 5 days
under air-liquid interface conditions.
This observation was confirmed in the
immunofluorescence studies where expression
of the ATII cell–specific marker HTII-280
decreased and the ATI cell–specific marker
AQP-5 increased with air-liquid interface
cultured fresh ATII cells (29). Hierarchical
clustering heat maps from RNA deep
sequencing analyses revealed that gene
expression in cells grown with feeder cells and
“Y” was systematically different from gene
expression in freshly isolated and cultured
cells (Figure 4A). Pearson’s coefficients
revealed that passaged (plastic and air-liquid
interface) cells correlated more tightly with
transdifferentiating ATII cells grown at air-
liquid interface for 5 days than freshly isolated
ATII cells (Figure 4B). From
these observations, we conclude that it is likely
that the feeder cell and “Y” approach has
“broken” the cell cycle block in ATII cells and
ATII cells that had transdifferentiated into
“ATI-like” cells.
Previously, we demonstrated that
freshly isolated human ATII cultures
in vitro have the capacity to actively absorb
(ENaC-mediated) or secrete (CFTR-
dependent) ions and liquid, respectively, in
response to local conditions and stimuli (29).
We wanted to explore whether ATII cells
that have undergone serial passage retained
ATII cell–specific activity. Our data revealed
that passaged (p2) ATII cells formed
confluent monolayers under air-liquid
interface conditions with basal resistances of
approximately 450 Vcm2 and an Isc of
approximately 15 mA/cm2, similar to freshly
cultured human ATII cells (Figure 5A).
Approximately 60% of the basal Isc of freshly
cultured ATII cells was sensitive to the
epithelial Na1 channel inhibitor amiloride,
whereas approximately 40% of the basal Isc
in passaged ATII cells was sensitive to
amiloride (Figure 5C). This slightly lower
Na1 current in passaged (p2) cells was
restored when these cells were cultured with
dexamethasone for 24 hours (Figure E2).
Similar basal CFTR-mediated Cl2
transport rates were observed in freshly
cultured and passaged ATII cells (Figures
5C and 5E). UTP-regulated Cl2 secretion
in passaged (p2) ATII cells was also similar
to freshly cultured ATII cells. The
nucleotide-mediated increase in Isc in both
cell types was highly dependent on the
function of CFTR. The functional data
were paralleled by RNA measurements.
ENaC subunit mRNA expression (a-, b-,
and, g-ENaC) was expressed similarly in
both conditions (Figure 5E and Table E3).
We previously demonstrated by mRNA
analyses that active Cl2 transport in
primary ATII cells is dominated by CFTR
(29), and CFTR mRNA levels were similar
in freshly isolated and passaged (p2) cells
(Figure 5F).
It remains difficult to understand the
relationship between ion transport measured
in Ussing chambers and the surface liquid
physiology within an intact alveolus. Using
confocal microscopy, we previously reported
that primary human ATII cells balance
absorption and secretion to maintain
a steady-state surface liquid height of
approximately 4 to 5 mm (29). When freshly
cultured and passaged (p2) ATII cells were
allowed to equilibrate after the addition of
a liquid bolus, they exhibited similar AvSL
heights at 24 hours (Figures 6A and 6B),
suggesting that passaged ATII cells retained
the capacity to balance Na1 versus Cl2
transport to maintain physiologic AvSL
heights. A key luminal regulator of
respiratory epithelial surface liquid
homeostasis (i.e., the nucleotide UTP)
produced AvSL secretion in passaged (p2)
feeder cells and “Y” grown cells similar to
freshly cultured ATII cells (Figures 6C and
6D). Finally, passaged ATII cultures
exhibited the ability to absorb a “flooded
volume” with similar absorptive kinetics
compared with freshly cultured cells
(Figure 6B). Overall, passaged ATII cultures
appear to be an excellent tool to study the
processes that regulates alveolar fluid
physiology and pathophysiology.
In conclusion, we used a recently
developed cell culture technique combining
feeder cells with a pharmacological inhibitor
of the Rho kinase signaling pathway to
“break” the ATII cell cycle block and
stimulate primary human ATII cell
proliferation for serial passage. Passaged
ATII cells formed confluent monolayers
under air–liquid interface conditions with
basal resistances, Na1 and Cl2 ion transport
properties, and AvSL regulation comparable
to freshly cultured cells. This technique will
increase the supply of human primary ATII
cells and will allow for additional studies to
be performed focused on important
biological and functional processes relevant
to the physiology and pathophysiology of
alveolar lung diseases. n
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